A Prototype Intelligent Hybrid System for Hard Gelatin Capsule Formulation Development

Publication
Article
Pharmaceutical TechnologyPharmaceutical Technology-09-02-2002
Volume 26
Issue 9

Decision-making tools such as expert systems and artificial neural networks can be integrated to facilitate the development of optimal formulations of hard gelatin capsules.

External Link - article-30359.pdf

Articles in this issue
Mixed-Flow Exhaust Technology: A New Approach for Energy Savings and Pollution Abatement
Innovations of Membrane Chromatography for Biomolecular Purification
New Syringe Designs Combine Prefilled Convenience with Safety
A Prototype Intelligent Hybrid System for Hard Gelatin Capsule Formulation Development
An Overview of the Validation Approach for Moist Heat Sterilization, Part I
Outsourcing Outlook
Spreading of Semisolid Formulations: An Update
Auditing Your Contractor
Attack Mounts on Drug Prices
Recent Videos
Drug Digest: Patient Preference Drives Solid Dosage Trends
Sheryl Johnson from Orbia Fluor & Energy Materials chats about gender diversity, how women are helping to advance innovation, sustainability challenges, and progress in the field of inhaled drugs.
Related Content
Text sign showing Industry News. Business photo text delivering news to the general public or a target public | Image Credit: © Artur - © Artur - stock.adobe.com

New CBER Director Appointed

Susan Haigney
May 7th 2025
Article

FDA chooses Dr. Vinay Prasad, MD, MPH, a hematologist-oncologist, to lead the Center for Biologics Evaluation and Research at FDA.

Drug Solutions Podcast: Applying Appropriate Analytics to Drug Development

Drug Solutions Podcast: Applying Appropriate Analytics to Drug Development

March 26th 2024
Podcast

In this episode of the Drug Solutions Podcast, Jan Bekker, Vice President of Business Development, Commercial and Technical Operations at BioCina, discusses the latest analytical tools and their applications in the drug development market.

Text sign showing Industry News. Business photo text delivering news to the general public or a target public | Image Credit: © Artur - stock.adobe.com

FDA Approves First Generics of Rivaroxaban Tablets

Patrick Lavery
March 12th 2025
Article

Rivaroxaban, long known under the brand name Xarelto, is an anticoagulant, a classification that is among the most-prescribed medications in the United States.

Drug Solutions Podcast: mRNA Past, Present, and Future

Drug Solutions Podcast: mRNA Past, Present, and Future

Chris Spivey
August 17th 2023
Podcast

An mRNA conversation about the recent past, current hot topics, and probable future.

Two dosing pens of a fictitious semaglutide drug (GLP-1) on a scale facing a dumbbell. Concept for alternative ways to loose weight. | Image Credit: © Andreas Prott - Stock.adobe.com

Next-Generation Anti-Obesity Medicines

Cheryl Barton
February 8th 2025
Article

European biopharma companies are looking beyond GLP-1s.

Hand shaking which print screen on wooden cube block in front of human icon for business deal and agreement concept | Image Credit: © Dilok – © Dilok - stock.adobe.com

Lonza and Iconovo Team Up on Intranasal Biologic Candidate

Feliza Mirasol
January 15th 2025
Article

Lonza will work with Iconovo to develop spray-dried formulations for an intranasally delivered biologic using a reformulated biologic drug candidate for obesity.